Orifarm
Orifarm, officially known as Orifarm Group, is a prominent player in the pharmaceutical industry, headquartered in Denmark (DK). Founded in 1994, the company has established itself as a leader in the development, production, and distribution of generic medicines and parallel imports, primarily serving the European market. With a strong focus on quality and accessibility, Orifarm offers a diverse portfolio of products, including prescription medications and over-the-counter solutions. Their commitment to innovation and sustainability sets them apart in a competitive landscape. Over the years, Orifarm has achieved significant milestones, including expanding its operational reach across multiple European countries. The company is recognised for its dedication to improving patient access to essential medicines, solidifying its position as a trusted partner in the healthcare sector.
DitchCarbon Score
How does Orifarm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Orifarm's score of 33 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Orifarm's reported carbon emissions
In 2023, Orifarm reported total carbon emissions of approximately 11,949,000 kg CO2e, comprising 4,420,000 kg CO2e from Scope 1 and 7,529,000 kg CO2e from Scope 2 emissions. This marks a significant increase from 2022, where total emissions were about 12,579,000 kg CO2e, with Scope 1 emissions at 4,315,000 kg CO2e and Scope 2 emissions at 8,264,000 kg CO2e. Orifarm has committed to achieving net-zero emissions across all scopes by 2050, with a near-term target status of "Committed" as of January 2023. The company is a member of the Science Based Targets initiative (SBTi) and is actively working towards its long-term climate goals. Over the years, Orifarm has demonstrated a commitment to reducing its carbon footprint, with emissions in 2021 reaching approximately 2,318,000 kg CO2e for Scope 1 and 940,000 kg CO2e for Scope 2. In contrast, emissions in 2020 were about 605,000 kg CO2e for Scope 1 and 395,000 kg CO2e for Scope 2, indicating a trend of increasing emissions in recent years. As a key player in the pharmaceuticals, biotechnology, and life sciences sector, Orifarm's climate commitments reflect a growing industry focus on sustainability and carbon reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 732,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 575,000 | 000,000 | 000,000 | 000,000 | 0,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Orifarm is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
